130 related articles for article (PubMed ID: 11763419)
1. Induction of apoptosis by estramustine phosphate mediated by phosphorylation of bcl-2.
Yoshida D; Noha M; Watanabe K; Takahashi H; Sugisaki Y; Teramoto A
J Neurooncol; 2001 Aug; 54(1):23-9. PubMed ID: 11763419
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced apoptosis by anti-microtubule agent, estramustine phosphate on human malignant glioma cell line, U87MG; in vitro study.
Yoshida D; Hoshino S; Shimura T; Takahashi H; Teramoto A
J Neurooncol; 2000 Apr; 47(2):133-40. PubMed ID: 10982154
[TBL] [Abstract][Full Text] [Related]
3. The bleb formation of the extracellular pseudopodia; early evidence of microtubule depolymerization by estramustine phosphate in glioma cell; in vitro study.
Yoshida D; Noha M; Watanabe K; Bergenheim T; Henriksson R; Teramoto A
J Neurooncol; 2001 Mar; 52(1):37-47. PubMed ID: 11451201
[TBL] [Abstract][Full Text] [Related]
4. Apoptotic tumor cell death induced by estramustine in patients with malignant glioma.
Vallbo C; Bergenheim AT; Bergström P; Gunnarsson PO; Henriksson R
Clin Cancer Res; 1998 Jan; 4(1):87-91. PubMed ID: 9516956
[TBL] [Abstract][Full Text] [Related]
5. Ondansetron but not granisetron affect cell volume regulation and potassium ion transport of glioma cells treated with estramustine phosphate.
Behnam-Motlagh P; Sandström PE; Henriksson R; Grankvist K
J Cancer Res Clin Oncol; 2002 Aug; 128(8):449-55. PubMed ID: 12200602
[TBL] [Abstract][Full Text] [Related]
6. Radiosensitizing effect of estramustine in malignant glioma in vitro and in vivo.
Bergenheim AT; Zackrisson B; Elfverson J; Roos G; Henriksson R
J Neurooncol; 1995; 23(3):191-200. PubMed ID: 7673981
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of estramustine and [3'-keto-Bmtl]-[Val2]-cyclosporine (PSC 833) on the inhibition of androgen receptor phosphorylation in LNCaP cells.
Wang LG; Liu XM; Budman DR; Kreis W
Biochem Pharmacol; 1999 Oct; 58(7):1115-21. PubMed ID: 10484069
[TBL] [Abstract][Full Text] [Related]
8. Effects of estramustine on DNA and cell membrane in malignant glioma cells.
von Schoultz E; Grankvist K; Gustavsson H; Henriksson R
Acta Oncol; 1991; 30(6):719-23. PubMed ID: 1958392
[TBL] [Abstract][Full Text] [Related]
9. The antimicrotubule drug estramustine but not irradiation induces apoptosis in malignant glioma involving AKT and caspase pathways.
Vallbo C; Bergenheim T; Hedman H; Henriksson R
J Neurooncol; 2002 Jan; 56(2):143-8. PubMed ID: 11995815
[TBL] [Abstract][Full Text] [Related]
10. Estramustine binding protein and anti-proliferative effect of estramustine in human glioma cell lines.
von Schoultz E; Lundblad D; Bergh J; Grankvist K; Henriksson R
Br J Cancer; 1988 Sep; 58(3):326-9. PubMed ID: 3052561
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of estramustine phosphate.
Bergenheim AT; Henriksson R
Clin Pharmacokinet; 1998 Feb; 34(2):163-72. PubMed ID: 9515186
[TBL] [Abstract][Full Text] [Related]
12. Androgen antagonistic effect of estramustine phosphate (EMP) metabolites on wild-type and mutated androgen receptor.
Wang LG; Liu XM; Kreis W; Budman DR
Biochem Pharmacol; 1998 May; 55(9):1427-33. PubMed ID: 10076535
[TBL] [Abstract][Full Text] [Related]
13. Tumor blood flow and the cytotoxic effects of estramustine and its constituents in a rat glioma model.
Johansson M; Bergenheim AT; Henriksson R; Koskinen LO; Vallbo C; Widmark A
Neurosurgery; 1997 Jul; 41(1):237-43; discussion 243-4. PubMed ID: 9218312
[TBL] [Abstract][Full Text] [Related]
14. Selective antimitotic effects of estramustine correlate with its antimicrotubule properties on glioblastoma and astrocytes.
Yoshida D; Cornell-Bell A; Piepmeier JM
Neurosurgery; 1994 May; 34(5):863-7; discussion 867-8. PubMed ID: 8052384
[TBL] [Abstract][Full Text] [Related]
15. DNA fragmentation induced by the antimitotic drug estramustine in malignant rat glioma but not in normal brain--suggesting an apoptotic cell death.
Vallbo C; Bergenheim T; Bergh A; Grankvist K; Henriksson R
Br J Cancer; 1995 Apr; 71(4):717-20. PubMed ID: 7710934
[TBL] [Abstract][Full Text] [Related]
16. In vitro inhibition of cell proliferation, viability, and invasiveness in U87MG human glioblastoma cells by estramustine phosphate.
Yoshida D; Piepmeier JM; Teramoto A
Neurosurgery; 1996 Aug; 39(2):360-6. PubMed ID: 8832674
[TBL] [Abstract][Full Text] [Related]
17. Altered nuclear localization of bax protein in BCNU-resistant glioma cells.
Joy A; Panicker S; Shapiro JR
J Neurooncol; 2000 Sep; 49(2):117-29. PubMed ID: 11206007
[TBL] [Abstract][Full Text] [Related]
18. Effects of estramustine and its constituents on human malignant glioma cells.
von Schoultz E; Lundgren E; Henriksson R
Anticancer Res; 1990; 10(3):693-6. PubMed ID: 2369085
[TBL] [Abstract][Full Text] [Related]
19. Microtubule inhibitor D-24851 induces p53-independent apoptotic cell death in malignant glioma cells through Bcl-2 phosphorylation and Bax translocation.
Ito H; Kanzawa T; Kondo S; Kondo Y
Int J Oncol; 2005 Mar; 26(3):589-96. PubMed ID: 15703812
[TBL] [Abstract][Full Text] [Related]
20. Suppression of matrix metalloproteinase-2-mediated cell invasion in U87MG, human glioma cells by anti-microtubule agent: in vitro study.
Yoshida D; Piepmeier JM; Bergenheim T; Henriksson R; Teramoto A
Br J Cancer; 1998; 77(1):21-5. PubMed ID: 9459141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
